SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-006991
Filing Date
2023-03-08
Accepted
2023-03-08 16:21:24
Documents
1
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167831047096030.html 4  
1 FORM 4 wf-form4_167831047096030.xml 4 3477
  Complete submission text file 0001628280-23-006991.txt   4973
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Koenig Sheldon L. (Reporting) CIK: 0001766524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 23716381